Sara Alsaleh

ORCID: 0000-0002-2191-1650
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Child and Adolescent Psychosocial and Emotional Development
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 epidemiological studies
  • COVID-19 and Mental Health
  • Racial and Ethnic Identity Research
  • Prostate Cancer Treatment and Research
  • Estrogen and related hormone effects
  • Youth Education and Societal Dynamics
  • Optimism, Hope, and Well-being
  • Maternal Mental Health During Pregnancy and Postpartum
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Family Support in Illness

King Saud Medical City
2020

King Saud University
2020

Saudi Aramco Medical Services Organization
2020

There is growing concern about the adverse metabolic and cardiovascular effects of abiraterone acetate (AA) enzalutamide (ENZ), two standard hormonal therapies for prostate cancer. We analysed risk events among patients treated with AA ENZ.

10.2340/1651-226x.2024.20337 article EN cc-by Acta Oncologica 2024-04-09

The COVID-19 pandemic is expected to cause significant morbidity and mortality. development of an effective vaccine will take several months become available, its affordability unpredictable. Transfusion convalescent plasma (CP) may provide passive immunity. Based on initial data from China, a group hematologists, infectious disease specialists, intensivists drafted this protocol in March 2020.The aim study test the feasibility, safety, efficacy CP treating patients with across Saudi...

10.2196/23543 article EN cc-by JMIR Research Protocols 2020-09-08

(1) Background: Since the pandemic, adolescent girls have increasingly faced mental health challenges. We examined prevalence trends and associated risk factors for depression among girls. 2) Methods: Data aged 12 to 17 years (N=4346) from 2021 cross-sectional National Survey on Drug Use Health were analyzed. Factors with using multiple regression analysis. (3) Results: Rates of severe significantly higher (p<.001) in older (adjusted odds ratio [AOR]: 1.63, 1.61, those who did not...

10.20944/preprints202402.0233.v1 preprint EN 2024-02-05

(1) Background: Adolescent girls have increasingly faced mental health challenges. We examined prevalence trends and associated risk factors for depression among adolescent girls. (2) Methods: Data aged 12 to 17 years (N=4346) from the 2021 cross-sectional National Survey on Drug Use Health were analyzed. Factors with using multiple regression analysis. (3) Results: Rates of severe significantly higher (p<.001) in older (adjusted odds ratio [AOR]: 1.63, 1.61, those who did not...

10.20944/preprints202408.1451.v1 preprint EN 2024-08-20

(1) Background: Adolescent girls have increasingly faced mental health challenges. We examined prevalence trends and associated risk factors for depression among adolescent girls. (2) Methods: Data aged 12 to 17 years (N = 4346) from the 2021 cross-sectional National Survey on Drug Use Health were analyzed. Factors with using multiple regression analysis. (3) Results: Rates of severe significantly higher (p < 0.001) in older (adjusted odds ratio [AOR]: 1.63, 1.61), those who did not...

10.3390/adolescents4030029 article EN cc-by Adolescents 2024-08-31

Background: Much of the research on effect COVID-19 pandemic mental health has overlooked experiences adolescent boys. Objective: To examine prevalence depression, treatment trends, and associated risk factors among boys, controlling for year. Methods: Data boys aged 12 to 17 years (n = 4518) in 2021 National Survey Drug Use Health were analyzed. Time trends with depression examined using a multiple regression analysis. Results: The 12-month major depressive episodes (TMDEs) was 11.6% during...

10.3390/adolescents3040045 article EN cc-by Adolescents 2023-10-25

<sec> <title>BACKGROUND</title> The COVID-19 pandemic is expected to cause significant morbidity and mortality. development of an effective vaccine will take several months become available, its affordability unpredictable. Transfusion convalescent plasma (CP) may provide passive immunity. Based on initial data from China, a group hematologists, infectious disease specialists, intensivists drafted this protocol in March 2020. </sec> <title>OBJECTIVE</title> aim study test the feasibility,...

10.2196/preprints.23543 preprint EN cc-by 2020-08-15
Coming Soon ...